Task: Answer the multiple choice question.
Query: Which drug exhibits a 16.736% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a: Cc1ccccc1NC(=O)CC1SC(=O)N(c2ccccc2)C1=O
b: Cn1nnnc1SCc1ccc(C(=O)Nc2ccc(Br)cc2)cc1
c: Cc1cc(C(=O)Nc2ccccc2C(=O)O)c(C)o1
d: O=C(N1CCCCC1)N1CCN(S(=O)(=O)c2ccccc2)CC1
Answer: b. Cn1nnnc1SCc1ccc(C(=O)Nc2ccc(Br)cc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1nnnc1SCc1ccc(C(=O)Nc2ccc(Br)cc2)cc1
Cn1nnnc1SCc1ccc(C(=O)Nc2ccc(Br)cc2)cc1
N-(4-bromophenyl)-4-[(1-methyltetrazol-5-yl)sulfanylmethyl]benzamide